Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 755 of 1,261

  1. US 9023371

    Drug releasing coatings for medical devices

    Lutonix, Inc. · Granted May 5, 2015 · Expires Apr 30, 2035

    granted

  2. US 9024069

    NONOate derivatives and uses thereof

    IRONWOOD PHARMACEUTICALS, INC. · Granted May 5, 2015 · Expires Apr 30, 2035

    granted

  3. US 9023823

    Micro-RNA's that regulate muscle cells

    The Board of Regents of the University of Texas System · Granted May 5, 2015 · Expires Apr 30, 2035

    granted

  4. US 9023858

    Substituted pyrido[2,3-d]pyrimidines as delta-5-desaturase inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 5, 2015 · Expires Apr 30, 2035

    granted

  5. IL 172160

    Method for non-invasive quantification of perfusion in a tissue

    BRACCO SUISSE SA [CH] · Granted Apr 30, 2015 · Expires Apr 25, 2035

    granted

  6. US 9018244

    Benzopyran compounds, compositions and uses thereof

    Olema Pharmaceuticals, Inc. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  7. US 9018380

    Heterocyclic modulators of HIF activity for treatment of disease

    Boards of Regents, The University of Texas System · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  8. US 9018356

    Anti-ANGPTL3 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  9. US 9018201

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency

    BIOMARIN PHARMACEUTICAL INC. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  10. US 9018175

    3,4,4a,10b-Tetrahydro-1H-thiopyrano-[44,3-c] isoquinoline derivatives

    TAKEDA GMBH · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  11. US 9017730

    Compositions and uses of materials with high antimicrobial activity and low toxicity

    The Regents of the University of California · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  12. US 9017644

    Methods of treating autoimmune disorders and/or inflammatory disorders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  13. US 9018210

    Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation

    The Regents of the University of California · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  14. US 9018371

    Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  15. US 9018367

    Single stranded DNA aptamers binding NF-κB/RelA

    The Board of Regents of the University of Texas System · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  16. US 9018374

    Crystal of amide compound

    Takeda Pharmaceutical Company Limited · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  17. US 9018251

    Method for treating brain cancer or reducing temozolomide-resistance of brain cancer cells

    China Medical University · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  18. US 9018236

    Cyclodextrin-based microemulsions, and dermatological uses thereof

    Precision Dermatology, Inc. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  19. US 9018227

    Nicotinic acetylcholine receptor agonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  20. US 9018216

    Solid forms of (R)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1H-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  21. US 9018204

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  22. US 9017982

    Non-wild-type organophosphorus acid anhydrolases for enzymatic decontamination

    The United States of America as represented by the Secretary of the Army · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  23. US 9018170

    Reduced volume formulation of glatiramer acetate and methods of administration

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  24. US 9018162

    Methods for rapidly treating severe hypoglycemia

    XERIS PHARMACEUTICALS, INC. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.